CAPR- Capricor Therapeutics, Inc.

Name: Capricor Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Capricor Therapeutics, Inc. (CAPR) has 11 insiders with recent SEC Form 4 filings, including 10 buys and 2 sells. CAPR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CFO	Bergmann Anthony	116.1K	$3.07M	-900
Other	Maurer Michael T	80.0K	$2.12M	-
Dir	Litvack Frank	50.0K	$1.32M	-
CEO	Marban Linda	50.0K	$1.32M	-
VP	Krasney Karen	30.5K	$807.7K	-900

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 6, 2022	Avat Xavier48	Chief Business Officer	Buy	2,500	$3.73	$9,322.85	+100.0%	+72.9%	+21.6%
Jun 29, 2022	Musket David B60	Director	Sale+OE	28,215	$3.77	$106,370.55	-68.9%	+54.0%	+27.7%
Jun 27, 2022	Musket David B60	Director	Sell	17,775	$4.44	$78,921.00	-30.3%	+30.6%	+12.0%
May 9, 2017	Manzo Louis	Director	Buy	10,000	$3.10	$31,000.00	+7.8%	-	-
May 9, 2017	Musket David B60	Director	Buy	25,000	$3.10	$77,500.00	New	-	-
May 9, 2017	Cedars Sinai Medical Center	10% Owner	Buy	1,145,161	$3.10	$3,549,999.10	+39.4%	-	-
Sep 21, 2016	Cedars Sinai Medical Center	10% Owner	Buy	312,500	$3.20	$1,000,000.00	+12.1%	-	-
Mar 16, 2016	St. John Edward A.	10% Owner	Buy	833,332	$2.40	$1,999,996.80	+97.9%	-	-
Mar 16, 2016	Gershell Leland	Chief Financial Officer	Buy	2,100	$2.40	$5,040.00	New	-	-
Mar 16, 2016	Krasney Karen	EVP, General Counsel	Buy	4,060	$2.40	$9,744.00	+57.2%	-	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC